OXBRYTA COMMERCIAL: VIDEO TRANSCRIPT

NARRATOR:

“If you live with sickle cell, it's your time to experience less sickling with Oxbryta. The first of their kind FDA-approved tablets specifically designed to treat sickle cell. For patients 4 years and older.”

NARRATOR:

“Oxbryta is approved under accelerated approval based on an increase in hemoglobin. Continued approval may depend on verification of benefits in ongoing trials.”

NARRATOR:

“Don't take Oxbryta if you've had an allergic reaction to voxelotor or any ingredient in Oxbryta.”

NARRATOR:

“Oxbryta works at the source to reduce sickling and help red blood cells deliver oxygen throughout your body.”

NARRATOR:

“Common side effects are headache, diarrhea, stomach or abdominal pain, nausea, vomiting, rash, hives, and fever.”

NARRATOR:

“Tell your doctor which medicines and supplements you take or if you are pregnant or breastfeeding, or plan to be.”

NARRATOR:

“Oxbryta. It's your time to experience less sickling.”

NARRATOR:

“Ask your doctor about Oxbryta. If paying for Oxbryta is a challenge, GBT may be able to help.”